Arterial stiffness and angiotensinogen gene in hypertensive patients and mutant mice

Journal of Hypertension

Volumn 22, Issue 7, 2004, Pages 1299-1307

  Bozec, Erwan ^a   Lacolley, Patrick ^a   Bergaya, Sonia ^b   Boutouyrie, Pierre ^a   Meneton, Pierre ^b   Herissé Legrand, Monique ^a   Boulanger, Chantal M ^b   Alhenc Gelas, François ^b   Kim, Hyung Suk ^c   Laurent, Stéphane ^a,b   Dabiré, Hubert ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b INSERM   (France)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensinogen; Arterial stiffness; Essential hypertension; Genetic polymorphism; Mutant mice

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; PHENYLEPHRINE; VALSARTAN;

ADULT; AGED; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY COMPLIANCE; ARTERY WALL; ARTICLE; CAROTID ARTERY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY VASCULAR RESISTANCE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; EXPERIMENTAL MOUSE; FEMALE; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; INDUCED MUTATION; MAJOR CLINICAL STUDY; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; SPECIES COMPARISON; WILD TYPE; YOUNG MODULUS;

EID: 3042838364     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000125450.28861.63     Document Type: Article

References (39)

1. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241.
2. Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988; 77:14-13.
3. Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy BI, Safar ME, et al. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension 1994; 23:74-82.
4. Levy BI, Michel JB, Salzmann JL, Azizi M, Poitevin P, Safar M, et al. Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. Circ Res 1988; 63:227-239.
5. Safar ME, Van Bortel LM, Struijker-Boudier HA. Resistance and conduit arteries following converting enzyme inhibition in hypertension. J Vasc Res 1997; 34:67-81.
6. Benetos A, Topouchian J, Ricard S, Gautier S, Bonnardeaux A, Asmar R, et al. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension 1995; 26:44-47.
7. Lajemi M, Labat C, Gautier S, Lacolley P, Safar M, Asmar R, et al. Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. J Hypertens 2001; 19:407-413.
8. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-180.
9. Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA, Pratt JH, et al. Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 1997; 29:1078-1082.
10. Paillard F, Chansel D, Brand E, Benetos A, Thomas F, Czekalski S, et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 1999; 34: 423-429.
11. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, et al. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995; 96:687-692.
12. Jeunemaitre X, Gimenez-Roqueplo AP, Celerier J, Corvol P. Angiotensinogen variants and human hypertension. Curr Hypertens Rep 1999; 1: 31-41.
13. Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R, et al. M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens 1999; 17:9-17.
14. Bozec E, Fassot C, Tropeano AI, Boutouyrie P, Jeunemaitre X, Lacolley P, et al. Angiotensinogen gene M325T polymorphism and reduction in wall thickness in response to antihypertensive treatment. Clin Sci (Lond) 2003; 105:637-644.
15. Gould AB, Green D. Kinetics of the human renin and human substrate reaction. Cardiovasc Res 1971; 5:86-89.
16. Smithies O, Kim HS. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci USA 1994; 91:3612-3615.
17. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, et al. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A 1995; 92:2735-2739.
18. Corvol P, Persu A, Gimenez-Roqueplo AP, Jeunemaitre X. Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel. Hypertension 1999; 33:1324-1331.
19. Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S, et al. Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation 1999; 100:1387-1393.
20. Bussy C, Boutouyrie P, Lacolley P, Challande P, Laurent S. Intrinsic stiffness of the carotid arterial wall material in essential hypertensives. Hypertension 2000; 35:1049-1054.
21. Kelly R, Hayward C, Avolio A, O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation 1989; 80:1652-1669.
22. Hoeks APG, Boulanger MAP, Brands PJ, Hoeks AP, Willekes C, Boutouyrie P, et al. Automated detection of local artery wall thickness based on M-line signal processing. Ultrasound Med Biol 1997; 23:1017-1023.
23. Nichols WW, O'Rourke MF. Aging, high blood pressure and disease in humans. In: Nichols WW, O'Rourke MF (editors): McDonald's blood flow in arteries. theoretic, experimental and clinical principles, 3rd ed. London: Edward Arnold; 1990, pp. 398-420.
24. Tardy Y, Meister JJ, Perret F, Brunner HR, Arditi M. Non-invasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements. Clin Phys Physiol Meas 1991; 12:39-54.
25. Bezie Y, Lamaziere JM, Laurent S, Challande P, Cunha RS, Bonnet J, et al. Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1998; 18:1027-1034.
26. Boumaza S, Arribas SM, Osborne-Pellegrin M, McGrath JC, Laurent S, Lacolley P, et al. Fenestrations of the carotid internal elastic lamina and structural adaptation in stroke-prone spontaneously hypertensive rats. Hypertension 2001; 37:1101-117.
27. Lacolley P, Challande P, Boumaza S, Cohuet G, Laurent S, Boutouyrie P, et al. Mechanical properties and structure of carotid arteries in mice lacking desmin. Cardiovasc Res 2001; 51:178-187.
28. Bergaya S, Meneton P, Bloch-Faure M, Mathieu E, Alhenc-Gelas F, Levy BI, et al. Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice. Circ Res 2001; 88:593-599.
29. Fleis JL (editor). The design of clinical experiments. New York: John Wiley & Sons; 1986, pp. 241-262.
30. Cox RH. Basis for the altered arterial wall mechanics in the spontaneously hypertensive rat. Hypertension 1981; 3:485-495.
31. Balkestein EJ, Wang JG, Struijker-Boudier HA, Barlassina C, Bianchi G, Birkenhager WH, et al. Carotid and femoral intima-media thickness in relation to three candidate genes in a Caucasian population. J Hypertens 2002; 20:1551-1561.
32. Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo MS, Takahashi S, et al. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 1993; 268: 11617-11621.
33. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000; 52:639-672.
34. Tamura K, Nyui N, Tamura N, Fujita T, Kihara M, Toya Y, et al. Mechanism of angiotensin II-mediated regulation of fibronectin gene in rat vascular smooth muscle cells. J Biol Chem 1998; 273:26487-26496.
35. Tamura K, Chen YE, Lopez-Ilasaca M, Daviet L, Tamura N, Ishigami T, et al. Molecular mechanism of fibronectin gene activation by cyclic stretch in vascular smooth muscle cells. J Biol Chem 2000; 275:34619-34627.
36. Li C, Xu Q. Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cell Signal 2000; 12:435-445.
37. Sudhir K, Wilson E, Chatterjee K, Ives HE. Mechanical strain and collagen potentiate mitogenic activity of angiotensin II in rat vascular smooth muscle cells. J Clin Invest 1993; 92:3003-3007.
38. Kalinowski L, Matys T, Chabielska E, Buczko W, Malinski T. Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release. Hypertension 2002; 40:521-527.
39. Nickenig G, Laufs U, Schnabel P, Knorr A, Paul M, Bohm MP, et al. Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats. Br J Pharmacol 1997; 121:134-140.